메뉴 건너뛰기
Journal of Adolescent Health
Volumn 48, Issue 1, 2011, Pages 100-102
Erratum: HIV-infected adolescents: Relationship between atazanavir plasma levels and bilirubin concentrations (Journal of Adolescent Health (2011) 48, (100-102) DOI: 10.1016/j.jadohealth.2010.05.009);HIV-infected adolescents: Relationship between atazanavir plasma levels and bilirubin concentrations
Author keywords

Atazanavir; Children; HIV; Therapeutic drug monitoring
Indexed keywords

ATAZANAVIR; BILIRUBIN; RITONAVIR;
EID: 78650712750     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2011.02.002     Document Type: Erratum
Times cited : (7)
References (10)
  • 1
    • 0034641328 scopus 로고    scopus 로고
    • Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection: Italian Register for HIV Infection in Children and the Italian National AIDS Registry
    • M. de Martino, P.A. Tovo, and M. Balducci Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection Italian Register for HIV Infection in Children and the Italian National AIDS Registry JAMA 284 2000 190 197
    • (2000) JAMA , vol.284 , pp. 190-197
    • De Martino, M.1    Tovo, P.A.2    Balducci, M.3
  • 2
    • 34548598574 scopus 로고    scopus 로고
    • Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: Can they be applied to the current situation?
    • E. Ribera, L.F. Lopez-Cortes, and V. Soriano Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: Can they be applied to the current situation? Enferm Infecc Microbiol Clin 23 2005 55 67
    • (2005) Enferm Infecc Microbiol Clin , vol.23 , pp. 55-67
    • Ribera, E.1    Lopez-Cortes, L.F.2    Soriano, V.3
  • 3
    • 33748297583 scopus 로고    scopus 로고
    • Change to a once-daily combination including boosted atazanavir in HIV-1-infected children
    • E. Macassa, C. Delaugerre, and J.P. Teglas Change to a once-daily combination including boosted atazanavir in HIV-1-infected children Pediatr Infect Dis J 25 2006 809 814
    • (2006) Pediatr Infect Dis J , vol.25 , pp. 809-814
    • MacAssa, E.1    Delaugerre, C.2    Teglas, J.P.3
  • 4
    • 33646596272 scopus 로고    scopus 로고
    • Atazanavir plasma concentrations vary significantly between patients and correlate with increased serum bilirubin concentrations
    • D.E. Smith, S. Jeganathan, and J. Ray Atazanavir plasma concentrations vary significantly between patients and correlate with increased serum bilirubin concentrations HIV Clin Trials 7 2006 34 38
    • (2006) HIV Clin Trials , vol.7 , pp. 34-38
    • Smith, D.E.1    Jeganathan, S.2    Ray, J.3
  • 5
    • 0343338092 scopus 로고    scopus 로고
    • Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography
    • M. Sarasa-Nacenta, Y. Lopez-Pua, and J. Mallolas Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography J Chromatogr B Biomed Sci Appl 757 2001 325 332
    • (2001) J Chromatogr B Biomed Sci Appl , vol.757 , pp. 325-332
    • Sarasa-Nacenta, M.1    Lopez-Pua, Y.2    Mallolas, J.3
  • 6
    • 33749510684 scopus 로고    scopus 로고
    • Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers
    • D.M. Burger, S. Agarwala, and M. Child Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers Antimicrob Agents Chemother 50 2006 3336 3342
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 3336-3342
    • Burger, D.M.1    Agarwala, S.2    Child, M.3
  • 7
    • 49649103848 scopus 로고    scopus 로고
    • The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors
    • N. von Hentig, E. Babacan, and T. Lennemann The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors J Antimicrob Chemother 62 2008 579 582
    • (2008) J Antimicrob Chemother , vol.62 , pp. 579-582
    • Von Hentig, N.1    Babacan, E.2    Lennemann, T.3
  • 8
    • 65749113553 scopus 로고    scopus 로고
    • Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers
    • L. Dickinson, M. Boffito, and D. Back Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers J Antimicrob Chemother 63 2009 1233 1243
    • (2009) J Antimicrob Chemother , vol.63 , pp. 1233-1243
    • Dickinson, L.1    Boffito, M.2    Back, D.3
  • 9
    • 27544468948 scopus 로고    scopus 로고
    • In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation
    • D. Zhang, T.J. Chando, and D.W. Everett In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation Drug Metab Dispos 33 2005 1729 1739
    • (2005) Drug Metab Dispos , vol.33 , pp. 1729-1739
    • Zhang, D.1    Chando, T.J.2    Everett, D.W.3
  • 10
    • 34848861725 scopus 로고    scopus 로고
    • Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practice
    • J. Molto, J.R. Santos, and M. Valle Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practice Ther Drug Monit 29 2007 648 651
    • (2007) Ther Drug Monit , vol.29 , pp. 648-651
    • Molto, J.1    Santos, J.R.2    Valle, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.